Jove
Visualize
Contact Us

Related Experiment Videos

Tumor markers.

M J Seleznick1

  • 1Division of General Internal Medicine, University of South Florida College of Medicine, Tampa.

Primary Care
|December 1, 1992
PubMed
Summary
This summary is machine-generated.

Tumor markers aid in monitoring cancer recurrence and treatment response, guiding clinical decisions. Future research promises more sensitive and specific markers for early cancer detection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epidemiology versus outcome. The silicone breast implant controversy.

The Journal of rheumatology·1999
Same author

Scurvy is not a rare cause of pseudovasculitis: comment on the concise communication by Mehta et al.

Arthritis and rheumatism·1997
Same author

Esophagitis associated with the use of alendronate.

The New England journal of medicine·1996
Same author

Allergen-specific IgE levels and mite allergen exposure in children with acute asthma first seen in an emergency department and in nonasthmatic control subjects.

The Journal of allergy and clinical immunology·1996
Same author

Silicone gel implant explantation.

Plastic and reconstructive surgery·1995
Same author

Comparison of oral pulse methotrexate with placebo in the treatment of severe glucocorticosteroid-dependent asthma.

The Journal of allergy and clinical immunology·1994
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Oncology
  • Clinical Chemistry
  • Molecular Biology

Background:

  • Significant advancements in tumor marker detection, characterization, and clinical use over the past decade.
  • Limited utility in general cancer screening due to low disease prevalence in asymptomatic populations.
  • Primary care applications focus on monitoring disease recurrence and therapy response.

Purpose of the Study:

  • To review the current applications and future potential of tumor markers in cancer management.
  • To discuss the criteria for utilizing tumor marker levels to guide therapeutic decisions.
  • To highlight emerging technologies and research directions in tumor marker development.

Main Methods:

  • Review of recent literature on tumor marker advancements and clinical applications.

Related Experiment Videos

  • Discussion of diagnostic and prognostic roles of tumor markers.
  • Exploration of future research avenues, including molecular biology and imaging.

    • Main Results:

    • Tumor markers are valuable for monitoring treatment response and detecting recurrence, potentially reducing the need for exploratory surgery.
    • Specific criteria (treatment efficacy, early treatment benefit, accurate prediction) must be met to guide therapy based on marker levels.
    • Emerging applications include radionuclide imaging, radioimmunoguided surgery, and targeted drug delivery systems.

    Conclusions:

    • Tumor markers play a crucial role in post-treatment surveillance and can inform clinical vigilance.
    • Further research into molecular mechanisms and oncoproteins may lead to highly sensitive and specific markers for early cancer detection.
    • Future developments hold promise for improved cancer diagnosis, treatment, and patient outcomes.